HEART–BRAIN RELATIONSHIP: ATRIAL FIBRILLATION AND STROKE

REFERENCES

• European Stroke Initiative Recommendations for Stroke Management European Stroke Council, European Neurological Society and European Federation of Neurological Societies, Cerebrovasc. Dis. 2000; 10(5)335–351
   Google Scholar
• Bogousslavsky J., Kaplan L. Stroke Syndromes. Cambridge University Press. 1996
   Google Scholar
• Chant H., McCollum C. Stroke in Young Adults: The Role of Paradoxical Embolism. Thromb. Haemost. 2001; 85(1)22–29
   PubMed Web of Science ®Google Scholar
• Estrada-Quintero T., Kross D. E., Gorcsan J. 3rd Identification of a Malpositioned Atrial Pacemaker Lead Across a Patent Foramen Ovale by Transesophageal Echocardiography. J. Am. Soc. Echocardiogr. 1995; 8(4)560–562
   PubMedGoogle Scholar
• Palazzuoli A., Ricci D., Lenzi C., Lenzi J., Palazzuoli V. Transesophageal Echocardiography for Identifying Potential Cardiac Sources of Embolism in Patients with Stroke. Neurol. Sci. 2000; 21(4)195–202
   PubMed Web of Science ®Google Scholar
• Leys D., Mounier-Vehier F. Stroke Prevention. Current Opinion of Cerebrovascular Diseases, M. Fisher, J. Bogousslavsky, 1995; Vol. 2: 13 pp
   Google Scholar
• Feinberg W. M., Blackshear J. L., Laupacis A., Kronmal R., Hart R. G. Prevalence, Age Distribution, and Gender of Patients with Atrial Fibrillation. Arch. Intern. Med. 1995; 155: 469–473
   PubMed Web of Science ®Google Scholar
• Michelena H. I., Ezekowitz M. D. Atrial Fibrillation: Are There Gender Differences? Gend. Specif. Med. 2000; 3(6)44–49
   PubMedGoogle Scholar
• Wolf P. A., D'Agostino R. B., Belanger A. J., Kannel W. B. Probability of Stroke: A Risk Profile from the Framingham Study. Stroke 1991; 22: 312–318
   PubMed Web of Science ®Google Scholar
• Wolf P. A., Dawber T. R., Thomas H. E., Jr., Kannel W. B. Epidemiological Assessment of Chronic Atrial Fibrillation and the Risk of Stroke: The Framingham Study. Neurology 1978; 28: 973–977
   PubMed Web of Science ®Google Scholar
• Jørgensen H. S., Nakayama H., Reith J., Raasschou H. O., Olsen T. S. Acute Stroke with Atrial Fibrillation: The Copenhagen Stroke Study. Stroke 1996; 10: 1765–1769
   Google Scholar
• Lin H. J., Wolf P. A., Kelly-Hayes M., Beiser A. S., Kase C. S., Benjamin E. J., D'Agostino R. B. Stroke Severity in Atrial Fibrillation: The Framingham Study. Stroke 1996; 27: 1760–1764
   PubMed Web of Science ®Google Scholar
• Parnetti L., Gallai V. Atrial Fibrillation and Stroke. Cerebrovasc. Dis. 2000; 10(4)40–41
   PubMedGoogle Scholar
• Cerebral Embolism Study Group Stroke. Immediate Anticoagulation of Embolic Stroke: Brain Hemorrhage and Management Options. 1984; 15(5)779–789
   Google Scholar
• Cerebral Embolism Study Group. Immediate Anticoagulation of Embolic Stroke: A Randomized Trial. Stroke 1983; 14(5)668–776
   PubMed Web of Science ®Google Scholar
• The Stroke Prevention in Atrial Fibrillation Investigators. Predictors of Thromboembolism in Atrial Fibrillation: Part I, Clinical Features of Patients at Risk. Ann. Intern. Med. 1992; 116: 1–5
   PubMed Web of Science ®Google Scholar
• EAFT (European Atrial Fibrillation Trial) Study Group. European Atrial Fibrillation Trial: Secondary Prevention in Non-Rheumatic Atrial Fibrillation After Transient Ischaemic Attack or Minor Stroke. Lancet 1993; 342: 1255–1262
   Google Scholar
• Petersen P., Boysen G., Godtfredsen J., Andersen E. D., Andersen B. Placebo-Controlled, Randomised Trial of Warfarin and Aspirin for Prevention of Thromboembolic Complications in Chronic Atrial Fibrillation. The Copenhagen AFASAK Study. Lancet 1989; 333: 175–179
   Google Scholar
• The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. The Effects of Low-Dose Warfarin on the Risk of Stroke in Patients with Nonrheumatic Atrial Fibrillation. N. Engl. J. Med. 1990; 323: 1505–1511
   PubMed Web of Science ®Google Scholar
• Connolly S. J., Laupacis A., Gent M., Roberts R. S., Cairns J. A., Joyner C. Canadian Atrial Fibrillation Anticoagulation (CAFA) Study. J. Am. Coll. Cardiol. 1991; 18: 349–355
   PubMed Web of Science ®Google Scholar
• Ezekowitz M. D., Bridgers S. L., James K. E. Warfarin in the Prevention of Stroke Associated with Nonrheumatic Atrial Fibrillation. N. Engl. J. Med. 1992; 327: 1406–1412
   PubMed Web of Science ®Google Scholar
• Stroke Prevention in Atrial Fibrillation Investigators. Warfarin vs. Aspirin for Prevention of Thromboembolism in Atrial Fibrillation: Stroke Prevention in Atrial Fibrillation II Study. Lancet 1994; 343: 687–691
   Google Scholar
• SPAF III Writing Committee for the Stroke Prevention in Atrial Fibrillation Investigators. Patients with Nonvalvular Atrial Fibrillation at Low Risk of Stroke During Treatment with Aspirin: Stroke Prevention in Atrial Fibrillation III Study. JAMA 1998; 279: 1273–1277
   Google Scholar
• Krumholz H. M., Radford M. J., Ellerbeck E., Hennen J., Meehan T. P., Petrillo M., Wang Y., Kresowik T. F., Jencks S. F. Aspirin in the Treatment of Acute Myocardial Infarction in Elderly Medicare Beneficiaries: Patterns of Use and Outcome. Circulation 1995; 92: 2841–2847
   PubMed Web of Science ®Google Scholar
• Krumholz H. M., Radford M. J., Ellerbeck E., Hennen J., Meehan T. P., Petrillo M., Wang Y., Jencks S. F. Aspirin for Secondary Prevention After Acute Myocardial Infarction in the Elderly: Prescribed Use and Outcomes. Ann. Intern. Med. 1996; 124: 292–298
   PubMed Web of Science ®Google Scholar
• McCrory D. C., Matchar D. B., Samsa G., Sanders L. L., Pritchett E.L. C. Physician Attitudes About Anticoagulation for Nonvalvular Atrial Fibrillation in the Elderly. Arch. Intern. Med. 1995; 155: 277–281
   PubMed Web of Science ®Google Scholar
• Kutnner M., Nixon G., Silverstone F. Physicians Attitudes Toward Oral Anticoagulant and Antiplatelet Agents for Stroke Prevention in Elderly Patients with Atrial Fibrillation. Arch. Intern. Med. 1991; 151: 1950–1953
   PubMed Web of Science ®Google Scholar
• Brodsky M. A., Chun J. G., Podrid P. J., Douban S., Allen B. J., Cygan R. Regional Attitudes of Generalists, Specialists and Subspecialists about Management of Atrial Fibrillation. Arch. Intern. Med. 1996; 156: 2553–2562
   PubMed Web of Science ®Google Scholar
• Kalra L., Perez I., Melbourn A. Stroke Risk Management. Changes in Mainstream Practice. Stroke 1998; 29: 53–57
   PubMed Web of Science ®Google Scholar
• Carlsson J., Miketic S., Dees G., Haun S., Cuneo A., Tebbe U. Stroke Prevention Practices in Patients with Atrial Fibrillation and Pacemakertherapy: Evidence for Under-Use of Anticoagulation. Europace 2000; 2(2)115–118
   PubMed Web of Science ®Google Scholar
• Deplanque D., Corea F., Arquizan C., Parnetti L., Mas J. L., Gallai V., Leys D. and the SAFE I Study Investigators. Stroke and Atrial Fibrillation: Is Stroke Prevention Treatment Appropriate Beforehand? Heart 1999; 82: 563–569
   Google Scholar